![Ravi Rao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ravi Rao
Direttore/Membro del Consiglio presso
DBV TECHNOLOGIES
Patrimonio netto: - $ in data 31/05/2026
Profilo
Il Dr. Ravi M. Rao è Chief Medical Officer presso Swedish Orphan Biovitrum AB e membro del Royal College of Physicians. Fa parte del consiglio di amministrazione di DBV Technologies SA. Il dottor Rao è stato precedentemente impiegato come Chief Medical Officer presso Aeglea Biotherapeutics, Inc. e Head-Global Medical Affairs presso GlaxoSmithKline Plc. Si è laureato all'Università di Cambridge e ha conseguito un dottorato all'Imperial College di Londra.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Ravi Rao
| Società | Posizione | Inizio |
|---|---|---|
| DBV TECHNOLOGIES | Direttore/Membro del Consiglio | 19/05/2021 |
| AUTOLUS THERAPEUTICS PLC | Direttore/Membro del Consiglio | 01/04/2024 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Direttore Tecnico/Scientifico/R&S | 01/04/2022 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Investitore di Private Equity | 01/03/2022 |
Precedenti posizioni note di Ravi Rao
| Società | Posizione | Fine |
|---|---|---|
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01/11/2023 |
| SWEDISH ORPHAN BIOVITRUM AB | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
| SPYRE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 10/08/2020 |
| GSK PLC | Direttore Tecnico/Scientifico/R&S | 01/10/2019 |
Formazione di Ravi Rao
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
84
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Health Technology |
